2011
DOI: 10.1254/jphs.10305sc
|View full text |Cite
|
Sign up to set email alerts
|

Tonic Inhibition of Allergic Itch Signaling by the Descending Noradrenergic System in Mice

Abstract: Itch is a common complaint among patients with cutaneous diseases. H 1 histamine receptor antagonists are the drugs of choice for the treatment of itch, but their effect in ameliorating many pruritic diseases including atopic dermatitis is often unsatisfactory. The reason for this may be due in part to the presence of many itch mediators other than histamine (1), and therefore specific antagonists and inhibitors may not effectively relieve many kinds of pruritic diseases. Although at least two subpopulations o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
1
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(32 citation statements)
references
References 13 publications
0
30
1
1
Order By: Relevance
“…Because the antipruritic action of systemically administered milnacipran was reversed by intrathecal phentolamine, the effect of milnacipran is thought to be because of inhibited noradrenaline reuptake in the spinal dorsal horn. Intrathecal phentolamine (1.0 mg/site) increases itchrelated behavior in normal mice (3,4). In the present experiments, intrathecal phentolamine at the same dose inhibited the milnacipran action, but itchrelated behavior did not exceed a normal level.…”
Section: Short Communicationcontrasting
confidence: 42%
See 1 more Smart Citation
“…Because the antipruritic action of systemically administered milnacipran was reversed by intrathecal phentolamine, the effect of milnacipran is thought to be because of inhibited noradrenaline reuptake in the spinal dorsal horn. Intrathecal phentolamine (1.0 mg/site) increases itchrelated behavior in normal mice (3,4). In the present experiments, intrathecal phentolamine at the same dose inhibited the milnacipran action, but itchrelated behavior did not exceed a normal level.…”
Section: Short Communicationcontrasting
confidence: 42%
“…Recently, we have found the descending noradrenergic system to exert a tonic inhibition of itch signaling in the spinal cord through aadrenoceptors (3,4). Stimulation of either a 1 adrenoceptor or a 2 adrenoceptor in the spinal cord results in marked reduction in itchrelated behavior in mice (3,5).…”
Section: Short Communicationmentioning
confidence: 99%
“…46,47) The α 2 -adrenoceptor agonist clonidine and the serotonin-noradrenaline reuptake inhibitor milnacipran inhibited pruritogen-induced biting through their action on the spinal cord. 48,49) Under normal conditions, the descending serotonergic system does not seem to exert tonic inhibition of itch transmission.…”
Section: Biting Behaviorsmentioning
confidence: 99%
“…48,49) Under normal conditions, the descending serotonergic system does not seem to exert tonic inhibition of itch transmission. 47) …”
Section: Biting Behaviorsmentioning
confidence: 99%
“…Recently, a subpopulation of inhibitory interneurons expressing the transcription factor Bhlhb5 during the development was identified as the mediator of the pain evoked itch inhibition [11]. Furthermore, descending adrenergic pathways were also suggested to control the inhibitory interneurons of the spinal cord [32,33].…”
Section: Spinal Itch Processingmentioning
confidence: 99%